MedPath

Gender- and Culturally-Sensitive Weight Loss Intervention for Hispanic Males

Not Applicable
Completed
Conditions
Obesity
Overweight
Interventions
Behavioral: Counseling sessions
Behavioral: Wait List Control
Registration Number
NCT02783521
Lead Sponsor
University of Arizona
Brief Summary

The investigators propose to 1) assess the feasibility, acceptability and preliminary efficacy of a gender- and culturally-sensitive weight loss intervention in 48 overweight/obese Hispanic males ages 18-64 over 12 weeks; 2) assess participant characteristics and process measures related to the uptake of mobile-health (mHealth) technology in overweight/obese Hispanic males over 12 weeks; and 3) assess pathologic changes in the liver in Hispanic men enrolled in a 12-week weight loss intervention using a non-invasive MRI as a therapeutic response biomarker.

Detailed Description

In the U.S., Hispanic males have the highest rate of overweight and obesity when compared to males of other racial/ethnic groups placing them at greater risk for obesity-related disease. Yet, current literature is lacking to inform on best practices to engage Hispanic males in weight loss and/or to promote a successful weight loss trajectory. Without this information the health disparities associated with obesity and obesity-related chronic disease will continue. Evidence exists to support behavioral weight loss in reducing obesity-related health risks. There are limited data to suggest these programs are effective for men and no data to support the feasibility and effectiveness of these programs among Hispanic males despite this being the fastest growing and highest burdened group for obesity-related disease within the U.S. population. Using existing practice guidelines and evidence from recently completed in-depth qualitative interviews in overweight/obese Hispanic males, the investigators will test a novel intervention approach to address this gap in knowledge. The investigators propose to 1) assess the feasibility, acceptability and preliminary efficacy of a gender- and culturally-sensitive weight loss intervention in 48 overweight/obese Hispanic males ages 18-64 over 12 weeks; 2) assess participant characteristics and process measures related to the uptake of mobile-health (mHealth) technology in overweight/obese Hispanic males over 12 weeks; and 3) assess pathologic changes in the liver in Hispanic men enrolled in a 12-week weight loss intervention using a non-invasive MRI as a therapeutic response biomarker. This project will challenge current research paradigms for Hispanic males by testing a gender- and culturally-sensitive weight loss intervention and providing highly impactful formative research on the use of novel mHealth self-monitoring technologies to facilitate dietary/physical activity behavior changes. Given the Hispanic population is the fastest growing in the U.S., efforts to identify strategies to promote weight control among Hispanic males has potential to significantly impact public health. The expected outcome of the proposed project is the identification of feasible and appropriate weight loss intervention strategies to improve engagement and weight management in this vulnerable ethnic group.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
50
Inclusion Criteria
  • 18-64 years of age
  • BMI between 25 to 45.0 kg/m² (NOTE: The investigators elected to cap this at 45.0 kg/m² to minimize potential risks and to reduce the potential for obesity to limit exercise participation)
  • Ability to provide informed consent and health risk assessment prior to participation in this study
  • Speak, read, and write either English and/or Spanish
Exclusion Criteria
  • Uncontrolled diabetes mellitus
  • History of bariatric surgery
  • Report medical condition or treatment for a medical condition that could affect body weight or ability to engage in structured physical activity that is consistent with the intervention for this study
  • Current congestive heart failure, angina, uncontrolled arrhythmia, or other symptoms indicative of an increased acute risk for a cardiovascular event
  • Resting systolic blood pressure of ≥150 mmHg or resting diastolic blood pressure of ≥90 mmHg
  • Eating disorders that would contraindicate weight loss or physical activity
  • Alcohol or substance abuse
  • Currently treated for psychological issues (i.e. depression, bipolar disorder, etc.), taking psychotropic medications with the previous 12 months, or hospitalized for depression within the previous 5 years
  • Report exercise on ≥3 days per week for ≥ 20 minutes per day over the past 3 months
  • Report weight loss of ≥5% or participating in a weight reduction diet program in the past 3 months
  • Report plans to relocate to a location that limits their access to the study site or having employment, personal, or travel commitments that prohibit attendance to all of the scheduled assessments

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionCounseling sessionsIncludes changing eating behaviors, increasing physical activity, and attending regular in-person weight loss meetings for 12 weeks. To support additional weight loss/weight maintenance, participants will receive bi-weekly phone calls across a 12 week follow-up.
Wait List ControlWait List ControlWait-list control participants will not receive any intervention for the first 12 weeks. After 12 weeks, participants will receive the weight loss intervention plus mHealth technology support.
Primary Outcome Measures
NameTimeMethod
RetentionWeek 24

Retention will be measured as the number of participants who remain in the study at 24 weeks, divided by the number enrolled.

Study Recruitment: Interest in ParticipationBaseline

The number of Hispanic men who contact the researchers and express interest in participation.

Study Recruitment: Screened for EligibilityBaseline

The number of Hispanic men screened for eligibility.

Study Recruitment: EligibilityBaseline

The number of Hispanic men eligible/ineligible for study inclusion and reason for ineligibility.

Study Recruitment: EnrollmentBaseline

The number of Hispanic men enrolled in the study.

Treatment Satisfaction/AcceptabilityWeek 24

Participants will be asked to rate their overall satisfaction with the intervention at 24 weeks and if they would recommend the program to others. Participants will also be asked questions regarding satisfaction with their overall progress and for changing dietary and PA habits, and weight

Secondary Outcome Measures
NameTimeMethod
Change in body weight.6, 12, 18, and 24 weeks

Body weight will be measured on a digital scale to assess change in body weight over the intervention period.

Change in physical activity6, 12, 18, and 24 weeks

A questionnaire will be used to measure and quantify energy expenditure from physical activity.

Change in dietary intake12 and 24 weeks

A questionnaire will be used to assess self-reported food intake. This will be used to estimate calories, dietary fat, protein, and carbohydrates used.

Change in liver fat content (intervention only)12 weeks

A non-invasive MRI will be used to assess changes in liver fat content for intervention participants at week 12.

Trial Locations

Locations (1)

University of Arizona Collaboratory for Metabolic Disease Prevention and Treatment

🇺🇸

Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath